Glucagon
XSGP-302
Phase 3 small_molecule completed
Quick answer
Glucagon for Diabetes Mellitus, Type 1 is a Phase 3 program (small_molecule) at Xeris Biopharma Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xeris Biopharma Holdings
- Indication
- Diabetes Mellitus, Type 1
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed